(Q35576094)

8 August 2017

1 reference

title

Clinical impact of the new criteria for the diagnosis of diabetes mellitus (English)

1 reference

8 August 2017

Clinical Impact of the New Criteria for the Diagnosis of Diabetes Mellitus (English)

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.190

28 March 2024

author name string

Michael Small

3

1 reference

8 August 2017

Andrew F. B. Kernohan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14598876

28 March 2024

Colin G. Perry

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14598876

28 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14598876

28 March 2024

publication date

1 September 2003

1 reference

full work available at URL

8 August 2017

https://www.degruyter.com/document/doi/10.1515/CCLM.2003.190/pdf

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.190

Clinical Chemistry and Laboratory Medicine

28 March 2024

published in

1 reference

8 August 2017

volume

41

1 reference

8 August 2017

issue

9

1 reference

8 August 2017

page(s)

1239-1245

1 reference

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.190

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.190

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.190

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.190

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.190

Comparison of diabetes diagnostic categories in the U.S. population according to the 1997 American Diabetes Association and 1980-1985 World Health Organization diagnostic criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.190

The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.190

Comparison of the fasting and the 2-h glucose criteria for diabetes in different Asian cohorts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.190

Impact of new diagnostic criteria for diabetes on different populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.190

New diagnostic criteria for diabetes and mortality in older adults. DECODE Study Group. European Diabetes Epidemiology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.190

Diabetes in older adults: comparison of 1997 American Diabetes Association classification of diabetes mellitus with 1985 WHO classification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.190

Lack of agreement between the World Health Organization Category of impaired glucose tolerance and the American Diabetes Association category of impaired fasting glucose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.190

Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.190

Effects of changing diagnostic criteria on the risk of developing diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.190

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.190

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.190

The fasting plasma glucose cut-point predicting a diabetic 2-h OGTT glucose level depends on the phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.190

Hyperglycaemia and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.190

Oral glucose-tolerance tests and the diagnosis of diabetes: results of a prospective study based on the Whitehall survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.190

Development of retinopathy and proteinuria in relation to plasma-glucose concentrations in Pima Indians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.190

Fasting and two-hour post-load glucose levels for the diagnosis of diabetes. The relationship between glucose levels and complications of diabetes in the Pima Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.190

Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.190

Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.190

Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.190

Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.190

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

2

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.190

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

28 March 2024

5

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.190

Why use the oral glucose tolerance test?

28 March 2024

8

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.190

Is the oral glucose tolerance test obsolete?

28 March 2024

9

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.190

The reproducibility and usefulness of the oral glucose tolerance test in screening for diabetes and other cardiovascular risk factors.

28 March 2024

10

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.190

Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis

28 March 2024

12

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.190

Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group

28 March 2024

16

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.190

Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group

28 March 2024

22

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.190

Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies. The DECODE-study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis of Diagnostic Criteria in Europe

28 March 2024

27

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.190

Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes

28 March 2024

40

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.190

28 March 2024

Identifiers

1 reference

8 August 2017

1 reference